.avif)
.avif)
Sumitomo Pharma Email Format
Pharmaceutical Manufacturing
・
1,001-2,500 employees
・
Marlborough, MA, USA
Sumitomo Pharma America is a biopharmaceutical company focused on delivering therapeutic breakthroughs in oncology, urology, rare disease, cell and gene therapies, and CNS.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
first.last@us.sumitomo-pharma.com
Company Overview
Industry
Pharmaceutical Manufacturing
Headquarters
Marlborough, MA, USA
Revenue
$1B-$2.5B
FUNDING Stage
Subsidiary
Website
Key Executives
Toru Kimura (Representative Director, President and CEO), Motoyuki Sakai (Representative Director, Executive Vice President (Global Finance Administration)), Andrew Hetherington (Chief Technology & Quality Officer)
Tech Stack
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of Sumitomo Pharma?
Sumitomo Pharma uses the first.last format on us.sumitomo-pharma.com, so Jane Smith would be jane.smith@us.sumitomo-pharma.com.
What therapeutic areas does Sumitomo Pharma America focus on?
Sumitomo Pharma America focuses on oncology, CNS, urology, women's health, rare disease, and cell and gene therapies, with approved products including ORGOVYX, LATUDA, MYFEMBREE, GEMTESA, and RETHYMIC across these areas.
How many employees does Sumitomo Pharma have?
Sumitomo Pharma has approximately 1,143 employees. If you need to find a specific contact at Sumitomo Pharma, a tool like Clay can help you locate and verify individual email addresses quickly.
Which U.S. subsidiaries were consolidated to form Sumitomo Pharma America?
Sumitomo Pharma America was formed by consolidating seven U.S. affiliate companies, including Sunovion Pharmaceuticals, Myovant Sciences, Urovant Sciences, Enzyvant Therapeutics, Sumitovant Biopharma, Sumitomo Pharma Oncology, and Sumitomo Pharma America Holdings.
Who leads Sumitomo Pharma as its chief executive?
Sumitomo Pharma is led by Toru Kimura, who serves as Representative Director, President and CEO. The executive team also includes Motoyuki Sakai as Executive Vice President for Global Finance Administration and Andrew Hetherington as Chief Technology and Quality Officer.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating